2025-2031 Global Omalizumab for Injection Industry Research & Trends Analysis Report- YH Research

Home > Reports >Pharma & Healthcare > 2025-2031 Global Omalizumab for Injection Industry Research & Trends Analysis Report

2025-2031 Global Omalizumab for Injection Industry Research & Trends Analysis Report

Publication Date: 2025-08-19
Report Id: 2363967
Industry: Pharma & Healthcare
Report Page: 114
Chart: 120

PDF Download

Publication Date: 2025-08-19
Report Id: 2363967
Industry: Pharma & Healthcare
Report Page: 114
Chart: 120

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Omalizumab for Injection Definition
1.2 Global Omalizumab for Injection Market Size and Forecast
1.2.1 By Revenue, Global Omalizumab for Injection Market Size, 2020-2031
1.2.2 By Sales Volume, Global Omalizumab for Injection Market Size, 2020-2031
1.2.3 Global Omalizumab for Injection Price Trend, 2020-2031
1.3 China Omalizumab for Injection Market Size and Forecast
1.3.1 By Revenue, China Omalizumab for Injection Market Size, 2020-2031
1.3.2 By Sales Volume, China Omalizumab for Injection Market Size, 2020-2031
1.3.3 China Omalizumab for Injection Price Trend, 2020-2031
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Omalizumab for Injection Share in Global Market, 2020-2031
1.4.2 By Sales Volume, China Omalizumab for Injection Share in Global Market, 2020-2031
1.4.3 Omalizumab for Injection Market Size: China VS Global, 2020-2031
1.5 Omalizumab for Injection Market Dynamics
1.5.1 Omalizumab for Injection Market Drivers
1.5.2 Omalizumab for Injection Market Restraints
1.5.3 Omalizumab for Injection Industry Trends
1.5.4 Omalizumab for Injection Industry Policy

2 Global Competitive Landscape by Company
2.1 Global Omalizumab for Injection Revenue by Company, 2020-2025
2.2 Global Omalizumab for Injection Sales Volume by Company, 2020-2025
2.3 Global Omalizumab for Injection Price by Company, 2020-2025
2.4 Global Omalizumab for Injection Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Omalizumab for Injection Concentration Ratio
2.6 Global Omalizumab for Injection Mergers & Acquisitions, Expansion Plans
2.7 Global Omalizumab for Injection Manufacturers Product Type

3 China Competitive Landscape by Company
3.1 China Omalizumab for Injection Revenue by Company, 2020-2025
3.2 China Omalizumab for Injection Sales Volume by Company, 2020-2025
3.3 China Omalizumab for Injection Omalizumab for Injection Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.4 China Omalizumab for Injection Market, Sales Percentage of Local Players VS Foreign Players (2020-2025)
3.5 Chinese Local Players, Omalizumab for Injection Domestic VS Export
3.6 China Market, Omalizumab for Injection Import & Export
3.6.1 China Market, Omalizumab for Injection Import & Export, 2020-2031
3.6.2 China Omalizumab for Injection Import & Export Trends
3.6.3 Main Sources of China Omalizumab for Injection Import
3.6.4 Export Destination of China Omalizumab for Injection

4 Omalizumab for Injection Production by Region
4.1 Global Omalizumab for Injection Capacity, Production and Capacity Utilization, 2020-2031
4.2 Global Geographic Distribution of Omalizumab for Injection Manufacturers
4.3 Global Major Manufacturers, Omalizumab for Injection Capacity Expansion and Future Plans
4.4 Global Omalizumab for Injection Capacity by Region
4.5 Global Omalizumab for Injection Production by Region
4.5.1 Global Omalizumab for Injection Production & Forecast by Region, 2020 VS 2024 VS 2031
4.5.2 Global Omalizumab for Injection Production by Region, 2020-2025
4.5.3 Global Omalizumab for Injection Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Omalizumab for Injection Industry Chain
5.2 Omalizumab for Injection Upstream Analysis
5.2.1 Omalizumab for Injection Core Raw Materials
5.2.2 Main Manufacturers of Omalizumab for Injection Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Omalizumab for Injection Production Mode
5.6 Omalizumab for Injection Procurement Model
5.7 Omalizumab for Injection Industry Sales Model and Sales Channels
5.7.1 Omalizumab for Injection Sales Model
5.7.2 Omalizumab for Injection Typical Distributors

6 Sights by Type
6.1 Omalizumab for Injection Classification
6.1.1 Subcutaneous Powder For Injection
6.1.2 Subcutaneous Solution (150 mg/mL)
6.1.3 Subcutaneous Solution(75 mg/0.5 mL)
6.2 by Type, Global Omalizumab for Injection Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Omalizumab for Injection Revenue, 2020-2031
6.4 by Type, Global Omalizumab for Injection Sales Volume, 2020-2031
6.5 by Type, Global Omalizumab for Injection Price, 2020-2031

7 Sights by Application
7.1 Omalizumab for Injection Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.2 by Application, Global Omalizumab for Injection Market Size & CAGR, 2020 VS 2024 VS 2031
7.3 by Application, Global Omalizumab for Injection Revenue, 2020-2031
7.4 by Application, Global Omalizumab for Injection Sales Volume, 2020-2031
7.5 by Application, Global Omalizumab for Injection Price, 2020-2031

8 Sales Sights by Region
8.1 By Region, Global Omalizumab for Injection Market Size, 2020 VS 2024 VS 2031
8.2 By Region, Global Omalizumab for Injection Revenue, 2020-2031
8.3 By Region, Global Omalizumab for Injection Sales Volume, 2020-2031
8.4 North America
8.4.1 North America Omalizumab for Injection Market Size & Forecasts, 2020-2031
8.4.2 By Country, North America Omalizumab for Injection Market Size Market Share
8.5 Europe
8.5.1 Europe Omalizumab for Injection Market Size & Forecasts, 2020-2031
8.5.2 By Country, Europe Omalizumab for Injection Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Omalizumab for Injection Market Size & Forecasts, 2020-2031
8.6.2 By Country/Region, Asia Pacific Omalizumab for Injection Market Size Market Share
8.7 South America
8.7.1 South AmericaOmalizumab for Injection Market Size & Forecasts, 2020-2031
8.7.2 By Country, South America Omalizumab for Injection Market Size Market Share
8.8 Middle East & Africa

9 Sales Sights by Country Level
9.1 By Country, Global Omalizumab for Injection Market Size & CAGR，2020 VS 2024 VS 2031
9.2 By Country, Global Omalizumab for Injection Revenue, 2020-2031
9.3 By Country, Global Omalizumab for Injection Sales Volume, 2020-2031
9.4 United States
9.4.1 United States Omalizumab for Injection Market Size, 2020-2031
9.4.2 By Company, United States Omalizumab for Injection Sales Volume Market Share, 2024
9.4.3 by Type, United States Omalizumab for Injection Market Size, Share, 2024 VS 2031
9.4.4 by Application, United States Omalizumab for Injection Market Size, Share, 2024 VS 2031
9.5 Europe
9.5.1 Europe Omalizumab for Injection Market Size, 2020-2031
9.5.2 By Company, Europe Omalizumab for Injection Sales Volume Market Share, 2024
9.5.3 by Type, Europe Omalizumab for Injection Market Size, Share, 2024 VS 2031
9.5.4 by Application, Europe Omalizumab for Injection Market Size, Share, 2024 VS 2031
9.6 China
9.6.1 China Omalizumab for Injection Market Size, 2020-2031
9.6.2 By Company, China Omalizumab for Injection Sales Volume Market Share, 2024
9.6.3 by Type, China Omalizumab for Injection Market Size, Share, 2024 VS 2031
9.6.4 by Application, China Omalizumab for Injection Market Size, Share, 2024 VS 2031
9.7 Japan
9.7.1 Japan Omalizumab for Injection Market Size, 2020-2031
9.7.2 By Company, Japan Omalizumab for Injection Market Share, 2024
9.7.3 by Type, Japan Omalizumab for Injection Market Size, Share, 2024 VS 2031
9.7.4 by Application, Japan Omalizumab for Injection Market Size, Share, 2024 VS 2031
9.8 South Korea
9.8.1 South Korea Omalizumab for Injection Market Size, 2020-2031
9.8.2 By Company, South Korea Omalizumab for Injection Market Share, 2024
9.8.3 by Type, South Korea Omalizumab for Injection Market Size, Share, 2024 VS 2031
9.8.4 by Application, South Korea Omalizumab for Injection Market Size, Share, 2024 VS 2031
9.9 Southeast Asia
9.9.1 Southeast Asia Omalizumab for Injection Market Size, 2020-2031
9.9.2 By Company, Southeast Asia Omalizumab for Injection Market Share, 2024
9.9.3 by Type, Southeast Asia Omalizumab for Injection Market Size, Share, 2024 VS 2031
9.9.4 by Application, Southeast Asia Omalizumab for Injection Market Size, Share, 2024 VS 2031
9.10 India
9.10.1 India Omalizumab for Injection Market Size, 2020-2031
9.10.2 By Company, India Omalizumab for Injection Market Share, 2024
9.10.3 by Type, India Omalizumab for Injection Market Size, Share, 2024 VS 2031
9.10.4 by Application, India Omalizumab for Injection Market Size, Share, 2024 VS 2031
9.11 Middle East & Africa
9.11.1 Middle East & Africa Omalizumab for Injection Market Size, 2020-2031
9.11.2 By Company, Middle East & Africa Omalizumab for Injection Market Share, 2024
9.11.3 by Type, Middle East & Africa Omalizumab for Injection Market Size, Share, 2024 VS 2031
9.11.4 by Application, Middle East & Africa Omalizumab for Injection Market Size, Share, 2024 VS 2031

10 Manufacturers Profile
10.1 Roche
10.1.1 Roche Company Information, Head Office, Market Area, and Industry Position
10.1.2 Roche Omalizumab for Injection Models, Specifications, and Application
10.1.3 Roche Omalizumab for Injection Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.1.4 Roche Company Profile and Main Business
10.1.5 Roche Recent Developments
10.2 Novartis
10.2.1 Novartis Company Information, Head Office, Market Area, and Industry Position
10.2.2 Novartis Omalizumab for Injection Models, Specifications, and Application
10.2.3 Novartis Omalizumab for Injection Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.2.4 Novartis Company Profile and Main Business
10.2.5 Novartis Recent Developments
10.3 CSPC Pharmaceutical Group
10.3.1 CSPC Pharmaceutical Group Company Information, Head Office, Market Area, and Industry Position
10.3.2 CSPC Pharmaceutical Group Omalizumab for Injection Models, Specifications, and Application
10.3.3 CSPC Pharmaceutical Group Omalizumab for Injection Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.3.4 CSPC Pharmaceutical Group Company Profile and Main Business
10.3.5 CSPC Pharmaceutical Group Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

According to YH Research, the global market for Omalizumab for Injection should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of %for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Omalizumab for Injection is a monoclonal antibody used primarily for the treatment of moderate to severe allergic asthma and chronic spontaneous urticaria. It works by specifically binding to immunoglobulin E (IgE), preventing IgE from interacting with its receptor, thereby inhibiting allergic and inflammatory responses. The medication is typically administered via subcutaneous injection and can improve symptoms and reduce acute exacerbations in long-term clinical management. In 2024, the global sales volume of Omalizumab for Injection reached approximately 26.39 million units, with an average price of 165 USD per unit.

Market Overview
The Omalizumab Injection market has maintained steady growth in recent years, driven by increasing demand for effective biologics among patients with allergic asthma and chronic spontaneous urticaria. Expansion of clinical guideline recommendations and long-term treatment protocols has improved market coverage, while the drug’s benefits in symptom management and prevention of acute exacerbations have contributed to overall market growth.

Regional Market Landscape
Globally, the United States accounts for 50% of the market, Europe 30%, Asia 15%, and other regions 5%, reflecting a market structure centered on North America with Europe following closely, while the Asian market is gradually expanding and emerging as a new growth area.

Key Manufacturers and Industry Competition
Roche and Novartis hold dominant positions as the primary developers and manufacturers worldwide, but competition is gradually intensifying with the emergence of biosimilars and other monoclonal antibodies. Companies maintain competitive advantages through scale expansion, global distribution networks, and clinical collaboration strategies, while enhancing product accessibility and patient coverage.

Technological Trends and Innovation Directions
Technological innovations focus on antibody structure optimization, development of long-acting formulations, and convenient delivery system design, which improve stability and patient adherence while supporting new indication expansion and combination therapy strategies. R&D progress is accelerating clinical application and market penetration.

Policy and Industry Development Drivers
Market development is driven by healthcare policy support, allergic disease prevention strategies, and optimized regulatory approvals for biologics. Clinical guideline recommendations and patient demand for innovative therapies further promote market expansion, while policy and public health factors jointly support long-term growth potential.

Future Outlook
Looking ahead, the Omalizumab Injection market is expected to maintain steady growth amid increasing global demand for allergic disease treatments, with potential increases in market concentration. Expansion into new indications, development of long-acting formulations, and regional market penetration will serve as key growth drivers. Technological innovation, policy support, and clinical adoption will collectively shape the long-term development landscape.

This report aims to provide a comprehensive study of the global market for Omalizumab for Injection.
Report Highlights:
(1) Global Omalizumab for Injection market size (sales volume & revenue), history data from 2020-2025, and forecast data from 2026 to 2031.

(2) Global Omalizumab for Injection market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(3) China Omalizumab for Injection market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(4) Global Omalizumab for Injection segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Omalizumab for Injection segment by Type, and by Application, and regional segment by Type, and by Application.

(6) Global major production regions of Omalizumab for Injection, capacity, production and trends.

(7) Omalizumab for Injection industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
Subcutaneous Powder For Injection
Subcutaneous Solution (150 mg/mL)
Subcutaneous Solution(75 mg/0.5 mL)

Market segment by Application, can be divided into
Hospital
Clinic

Market segment by players, this report covers
Roche
Novartis
CSPC Pharmaceutical Group